XSAT:CSMED (Denmark)
Â
Unit (5 Ord Shares & 2 Wrts Ser 1)
kr
5.00
(+2.25%)
Nov 29
Business Description
CS Medica AS
ISIN : DK0061668225
Share Class Description:
XSAT:CSMED: Unit (5 Ord Shares & 2 Wrts Ser 1)Compare
Compare
Traded in other countries / regions
CSMED.Sweden8G8.Germany IPO Date
2021-09-14Description
CS Medica AS is engaged in developing, manufacturing, and commercializing over-the-counter medical device products containing cannabinoids currently focusing on cannabidiol for the treatment of psoriasis and arthritis. It operates in two business segments such as GalaxaPharma A/S responsible for distribution operation for marketing and sales direct-to-consumer, to retailers, and e-tail and CANNORDIC A/S is engaged in research and development, establishing of global business contracts, supply of CBD ingredients and production of finished products.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | 0.05 | |||||
| Debt-to-Equity | 6.76 | |||||
| Debt-to-EBITDA | -0.97 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -1.1 | |||||
| Beneish M-Score | -4.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -23.5 | |||||
| 3-Year EPS without NRI Growth Rate | -518 | |||||
| 3-Year FCF Growth Rate | -90.4 | |||||
| 3-Year Book Growth Rate | 372.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 46.52 | |||||
| Future 3-5Y Total Revenue Growth Rate | 249.88 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 84.23 | |||||
| 9-Day RSI | 70.63 | |||||
| 14-Day RSI | 60.24 | |||||
| 6-1 Month Momentum % | 38.46 | |||||
| 12-1 Month Momentum % | 67.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.27 | |||||
| Quick Ratio | 0.19 | |||||
| Days Inventory | 286.3 | |||||
| Days Sales Outstanding | 187.42 | |||||
| Days Payable | 816.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.2 | |||||
| Shareholder Yield % | -13.86 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 38.8 | |||||
| Operating Margin % | -306.06 | |||||
| Net Margin % | -263.77 | |||||
| FCF Margin % | -63.64 | |||||
| ROE % | -162.07 | |||||
| ROA % | -41.2 | |||||
| ROIC % | -40.93 | |||||
| ROC (Joel Greenblatt) % | -665.15 | |||||
| ROCE % | -78.36 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 13.18 | |||||
| PB Ratio | 33.77 | |||||
| EV-to-EBIT | -5.51 | |||||
| EV-to-Forward-EBIT | -14.01 | |||||
| EV-to-EBITDA | -6.4 | |||||
| EV-to-Forward-EBITDA | -23.91 | |||||
| EV-to-Revenue | 17.42 | |||||
| EV-to-Forward-Revenue | 2.4 | |||||
| EV-to-FCF | -22.25 | |||||
| Earnings Yield (Greenblatt) % | -18.14 | |||||
| FCF Yield % | -4.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CS Medica AS Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 4.667 | ||
| EPS (TTM) (kr) | -0.999 | ||
| Beta | -1.19 | ||
| Volatility % | 254.7 | ||
| 14-Day RSI | 60.24 | ||
| 14-Day ATR (kr) | 0.642017 | ||
| 20-Day SMA (kr) | 4.1265 | ||
| 12-1 Month Momentum % | 67.14 | ||
| 52-Week Range (kr) | 2.01 - 11.45 | ||
| Shares Outstanding (Mil) | 13.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CS Medica AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CS Medica AS Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
CS Medica AS Frequently Asked Questions
What is CS Medica AS(XSAT:CSMED)'s stock price today?
The current price of XSAT:CSMED is kr5.00. The 52 week high of XSAT:CSMED is kr11.45 and 52 week low is kr2.01.
When is next earnings date of CS Medica AS(XSAT:CSMED)?
The next earnings date of CS Medica AS(XSAT:CSMED) is 2024-11-30.
Does CS Medica AS(XSAT:CSMED) pay dividends? If so, how much?
CS Medica AS(XSAT:CSMED) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers